Abstract
We have assessed short and long-term imprecision goals based on biological variation in haemocytometry through internal quality control (IQC) for the following parameters: white blood cell (WBC), red blood cell (RBC) and platelet (Plt) counts, concentration of haemoglobin (Hb) and mean cell volume (MCV). The attainment of short-term imprecision goals in the IQC system with our own and commercial control blood (between-day control) presents problem for MCV, where minimum performance is achievable, the analytical coefficient of variation (CV) being less than three-quarter of the average within-subject variation (CV I), i.e. CV<0.75 CV I. For the other four parameters desirable performance (CV<0.50 CV I) and even optimum performance—CV<0.25 CV I (for WBC and Hb) is achievable. The long-term desirable imprecision goals (CV L) based on within- and between-subject variation (CV G) seem to be too loose. However optimum performance \( {\left( {CV_{L} < 0.25{\left[ {CV^{2}_{I} + CV^{2}_{G} } \right]}^{{1 \mathord{\left/ {\vphantom {1 2}} \right. \kern-\nulldelimiterspace} 2}} } \right)} \) is attainable for all five basic haemocytometry parameters. In the IQC system with retained patient specimens (within-day control), short-term imprecision goals for optimum performance are surpassed for WBC and Hb and desirable performance is achieved for RBC, MCV and Plt.
Similar content being viewed by others
References
Fraser CG (1987) Am J Clin Pathol 88:667–669
Franzini C (1995) Ann Ist Super Sanita 31:9–13
NCCLS (1996) Performance goals for internal quality control of multichannel haematology analysers. Approved standard. Villanova, Pa., USA, 16:1–16
Skendzel LP, Barnett RN, Platt R (1985) Am J Clin Pathol 83:200–205
AACC (1988) Guidelines for providing quality stat laboratory services. AACC, Washington, US
NCCLS (1989) Performance goals for internal quality control of multichannel haematology analysers. Proposed standard. Villanova PA, US; 9:621–656
Westgard JO (1992) Arch Pathol Lab Med 116:765–769
Westgard JO, Stein B (1997) Clin Chem 43:400–403
Gowans EMS, Hyltoft Petersen P, Blaabjerg O, Horder M (1988) Scand J Clin Lab Invest 48:757–764
Harris EK (1979) Am J Clin Pathol 72:374–382
Fraser CG, Hyltoft Petersen P (1993) Clin Chem 39:1447–1455
Fraser CG, Hyltoft Petersen P, Libeer JC, Ricos C (1997) Ann Clin Biochem 34:8–12.
Fraser CG, Hyltoft Petersen P (1999) Clin Chem 45:321–323
Kallner A, McQeen M, Heuck C (1999) Scand J Clin Lab Invest 59:475–476
Fraser CG. Wilkinson SP, Neville RG, Knox JDE, King JF, MacWalter RS (1989) Am J Clin Pathol 92:465–470
Sebastian-Gambaro MA, Liron-Hernandez FJ, Fuentes-Arderin X (1997) Eur J Clin Chem Clin Biochem 35:845–852
Lombarts AJPF, Leijnse B (1984) Clin Chim Acta 139:145–154
Skitek M, Piskar M, Cerne D, Lukic L (1993) Ann Biol Clin 51:396
Skitek M (1996) Study of stabilisation mechanisms of flow haemocytometry control blood. Thesis. Ljubljana, University of Ljubljana, Faculty of pharmacy, Slovenia
Morgan LO, Hunt A (1984) Med Lab Sci 41:209–218
Hyltoft Petersen P, Ricos C, Stckl D, Libeer JC, Baadenhuijsen H, Fraser C, Thienpont L(1996) Eur J Clin Chem Clin Biochem 34:983–999
Skitek M (2002) EQAnews 13:29–31
Dybkaer R (1999) Scand J Clin Lab Invest 59:579–584
Hyltoft Petersen P, Stockl D, Westgard JO, Sandberg S, Linnet K, Thienpont L (2001) Clin Chem Lab Med 39:589–595
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skitek, M. Practical assessment of the suitability of IQC control materials in haemocytometry based on biologic goals. Accred Qual Assur 8, 514–519 (2003). https://doi.org/10.1007/s00769-003-0699-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00769-003-0699-4